+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Immunoglobulins in autoimmunity: history and mechanisms of action



Immunoglobulins in autoimmunity: history and mechanisms of action



Clinical and Experimental Rheumatology 14 Suppl 15: S3-S7



The search for preparations of human gammaglobulin that could be administered safely intravenously was driven by the need to better manage immune deficiency states. However, when suitable formulations were developed, it was soon realised that large infusions of immunoglobulin could be used to manipulate the immune system. The production of autoantibodies was minimised or their effects neutralised; T cell effector and regulatory function could be manipulated and cytokine release modified. More than fifty human disease states, many until now lacking safe and effective therapies, can be improved by the administration of intravenous immunoglobulin. Better understanding of the mechanisms involved will not only improve therapy but will provide a better understanding of the immunopathogenic mechanisms responsible.

(PDF emailed within 1 workday: $29.90)

Accession: 046333390

Download citation: RISBibTeXText

PMID: 8828941


Related references

Mechanisms of action of intravenous immunoglobulins. Fortschritte der Medizin 114(31): 420-424, 1996

Mechanisms of action of intravenous immunoglobulins. Expert Review of Clinical Immunology 6(3): 425-434, 2010

Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases. Annales de Medecine Interne 144(8): 506-513, 1993

Experimental autoimmunity to rat male accessory glands (MAG): circulating antibodies, immunoglobulins bound to target glands, and immunoglobulins-secreting cells. American Journal of Reproductive Immunology and Microbiology 7(1): 32-38, 1985

Intravenous immunoglobulins in multiple sclerosis. Studies and mechanisms of action--an update. Der Nervenarzt 73(2): 119-124, 2002

The therapy with immunoglobulins. Structure, mechanisms of action and the intravenous use of gammaglobulin preparations. Immunitat und Infektion 10(3): 98-109, 1982

Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. Current Neuropharmacology 7(4): 337-342, 2010

Autoimmunity, central axonal regeneration and Cyclosporine-A. In vitro observations on the action mechanisms. Rendiconti Lincei 6(1): 87-93, 1995

Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases. Current Pharmaceutical Design 17(29): 3166-3175, 2012

Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus. Autoimmunity Reviews 2019, 2019

Immunotherapy of high dose intravenous immunoglobulins: basic mechanisms of action and clinical implications. Polskie Archiwum Medycyny Wewnetrznej 106(5): 1071-1077, 2002

High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results. Annales de Medecine Interne 141(8): 689-697, 1990

Autoimmunity and counter-autoimmunity in the mechanisms of retrovirus-induced leukemogenesis. Leukemia 6 Suppl 3: 171s-173s, 1992

Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 60(3): 424-431, 2017

IgA immunoglobulins and autoimmunity. Lancet 2(7624): 804-805, 1969